Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion. The method using targeted lipid nanoparticles (tLNPs) is designed to deliver messenger RNA specifically to CD8+ T cells.
CAR T therapy has revolutionized the treatment of B-cell cancers, with lasting remissions in lupus, myositis, and leukemia and other B-cell–driven autoimmune disorders. The method requires the use of a patient’s own T cells, reengineering those T cells in a lab, growing the population of the modified cells and placing them back in the patient.
More than 20 million U.S. patients living with autoimmune conditions remain without access to the treatment as it depends on costly personalized lab processes, available at only a few specialized centers.
Capstan’s lipid-nanoparticle drug is formulated once, then administered to many patients without tailoring the genetic payload for each recipient, making it a universal option without the specialty center price tag or access obstacles.
In the study, “In vivo CAR T cell generation to treat cancer and autoimmune disease,” published in Science, researchers designed a lipid-nanoparticle delivery system to convert CD8+ T cells inside the body into transient anti-B-cell CAR T cells.
Experiments spanned humanized mice, primary human immune cells, and 22 cynomolgus monkeys given three doses of the therapeutic nanoparticle L829 (0.1–2.0 mg/kg).
A second cohort of 15 monkeys tested a two-dose schedule, and four additional animals examined steroid–antihistamine premedication. Pharmacokinetics, flow cytometry, imaging, and histology tracked CAR expression, B-cell counts, cytokines, and organ distribution.
Bioluminescent and fluorescent reporters confirmed reduced off-target expression in the liver and enhanced accumulation in spleen and lymphoid tissues compared with benchmark lipids used in mRNA vaccines. CD8-L829-tLNPs preferentially modified CD8+ T cells over CD4+ T cells, monocytes, and B cells.
CAR expression was detectable within six hours, declining by 72 hours. CAR T cells engineered in vivo exhibited antigen-specific cytotoxicity, cytokine production, proliferation, and serial killing capacity. Transfected T cells demonstrated effective clearance of CD19+ target cells in vitro.
In humanized mice, a single intravenous dose of 10 or 30 µg CD8-L829-tLNP-CD19 induced near-complete B cell depletion within three hours, with measurable CAR expression on CD8+ T cells persisting at 24 hours.
Nalm6 leukemia-bearing mice receiving the 30 µg dose exhibited near-total tumor clearance in four of five animals within two days of the first dose and complete clearance by the third day after treatment with a second dose.
In cynomolgus monkeys, two or three infusions of CD8-L829-tLNPs encoding an anti-CD20 CAR at 0.1 to 2.0 mg/kg resulted in rapid and profound B cell depletion across blood, spleen, and lymph nodes. CAR expression was observed in up to 85% of CD8+ T cells and 95% of CD8+ NK cells, with minimal expression in CD4+ populations. B cell repopulation began by day 21 and was characterized by a predominantly naive phenotype.
Mild and transient elevations in liver enzymes and pro-inflammatory cytokines, including interleukin-6 and interferon-gamma, were recorded at higher doses. One animal in the 1.5 mg/kg group was euthanized due to clinical features consistent with immune effector cell-associated hemophagocytic lymphohistiocytosis. A compact two-dose regimen replicated depletion efficacy while reducing cytokine release.
Targeted lipid nanoparticles enable in vivo generation of functional CAR T cells without requiring ex vivo cell manipulation or integrating viral vectors.
Researchers at Capstan Therapeutics demonstrated that lipid nanoparticle formulations bearing mRNA and conjugated to CD8-targeting antibodies can program T cells directly inside the body, offering a platform that bypasses conventional manufacturing, lymphodepletion, and the costly infrastructure required for existing CAR T therapies.
As lipid nanoparticle therapeutics are commercially scalable and already validated in mRNA vaccines, this technology may represent a foundational shift toward broader clinical use of engineered immunotherapy from within the patient’s body.
Written for you by our author Justin Jackson, edited by Sadie Harley, and fact-checked and reviewed by Robert Egan—this article is the result of careful human work. We rely on readers like you to keep independent science journalism alive. If this reporting matters to you, please consider a donation (especially monthly). You’ll get an ad-free account as a thank-you.
News
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Scientists Discover a Surprising New Power of Honey That Could Protect Your Skin
Honey’s medical uses may go beyond healing wounds, as laboratory experiments suggest multifloral honey could strengthen human skin cells’ defenses against damaging UV radiation. Ultraviolet (UV) radiation from sunlight can accelerate skin aging and [...]
Scientists Discover That Male and Female Hearts Age in Surprisingly Different Ways
A new study reveals surprising differences in how male and female hearts age at the cellular level. The heart may age very differently from one region to another. A detailed study of mouse hearts [...]
An Ancient Virus May Hold the Secret to What Makes the Human Brain Different
Could a virus that infected chimpanzees millions of years ago help explain how the human brain became different? Researchers at Lund University have discovered that ancient viral DNA embedded in the chimpanzee genome silences [...]
Could a Nasal Spray Stop Alzheimer’s Before Memory Loss Begins?
Protecting memory from Alzheimer’s may one day involve a nasal spray, with encouraging results in animals and evidence that its particles also protect human neurons grown in the lab. Alzheimer’s disease damages the connections [...]
A sceptical guide to AI agents in drug discovery
In conversation with Dr Eric Ma, Senior Principal Data Scientist at Moderna, Dr Raminderpal Singh examines what AI agents are actually good for, where the lock-in hides and why expertise has become more valuable [...]
Study identifies new targets for antiviral drugs against coronaviruses
A study led by researchers at the University of California San Diego School of Medicine and University of California, Riverside (UCR) School of Medicine has identified new targets for antiviral drugs against coronaviruses, including [...]
“Nearly Everybody Had Given Up” – Scientists Finally Solve a 60-Year Chemistry Mystery
After more than six decades of failed attempts, chemists have achieved a breakthrough involving a class of molecules long considered too unstable to isolate. Chemists have succeeded in isolating a group of molecules that [...]
Depression Symptoms Improved in Just 48 Hours After a Single Psychedelic Dose
A single dose of psilocybin produced rapid antidepressant effects in a small Swedish clinical trial, with improvements lasting for weeks. A single dose of psilocybin, the psychedelic compound found in magic mushrooms, produced rapid [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Human Bodies Are Producing Two Billion Tons of CO2 a Year
A new study reveals that the amount of carbon dioxide produced by human metabolism has increased dramatically over three decades. The carbon dioxide produced by human bodies as they convert food into energy increased [...]
A Hidden DNA Mechanism Could Explain How 20% of Human Cancers Develop
Researchers have identified an unexpected molecular vulnerability in cancers carrying BAF mutations. Mutations found in roughly 20% of human cancers may promote tumor growth by changing how DNA is organized inside cells. Researchers have [...]
Ebola kills over 5,300 in fastest-growing outbreak on record
Africa’s latest Ebola outbreak has killed nearly 5,400 people, the vast majority of them in the Democratic Republic of Congo (DRC), according to the continent’s top health agency. Africa Centres for Disease Control and [...]
China makes early progress in using sound waves to stimulate damaged brains
Chinese researchers are testing whether focused ultrasound can help restore consciousness in patients with severe brain injuries, adding to a growing international effort to use sound waves to stimulate deep brain structures without surgery. [...]
Micro-drones fly through the body thanks to ultrasound
At the EPFL, micro-drones have been developed that can be moved without a motor or battery.No motors, no batteries, no electronics on board, just small cavities that convert sound waves into thrust: this is [...]
A Single Enzyme Could Hold the Key to Treating a Devastating Brain Disorder
Blocking an enzyme’s production restored brain growth and healthy behaviors in mice engineered to develop Angelman syndrome, pointing to a possible treatment target. Children with Angelman syndrome begin to show difficulties with thinking and [...]















